Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.53 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.50 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.50 |
| ▸ | WDR5 | P61964 | 4/20 | 0.49 |
| ▸ | PDE10A | Q9Y233 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2821910 | 1.00 | PDE4A (0.53) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2819091 | 0.91 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2819086 | 0.91 | PDE4A (0.55) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2821723 | 0.85 | PDE10A (0.51) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2821726 | 0.85 | PDE10A (0.51) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL484112 | 0.84 | PDE4A (0.52) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL484111 | 0.84 | PDE4A (0.52) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL13131589 | 0.81 | PDE4A (0.48) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2816864 | 0.81 | TAS1R3 (0.57) | PDE4APDE4BPDE4CPDE4DTAS1R3 | |
| SCHEMBL2816865 | 0.81 | TAS1R3 (0.57) | PDE4APDE4BPDE4CPDE4DTAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | PDE4A 1509/4885PDE4B 1892/4885PDE4C 2205/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | PDE4A 1509/4885PDE4B 1892/4885PDE4C 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.